Aller au contenu

Publications scientifiques

  • article Ahmadi SA, Tranmer JE, Ritonja JA, Flaten L, Topouza DG, Duan QL, Durocher F, Aronson KJ, Bhatti P

    DNA methylation of circadian genes and markers of cardiometabolic risk in female hospital workers: An exploratory study

    Chronobiol Int 39 (5), 2022.

    DOI PUBMED
  • article Ritonja JA, Aronson KJ, Flaten L, Topouza DG, Duan QL, Durocher F, Tranmer JE, Bhatti P

    Exploring the impact of night shift work on methylation of circadian genes

    Epigenetics 17 (10), 2022.

    DOI PUBMED
  • article Ritonja JA, Aronson KJ, Leung M, Flaten L, Topouza DG, Duan QL, Durocher F, Tranmer JE, Bhatti P

    Investigating the relationship between melatonin patterns and methylation in circadian genes among day shift and night shift workers

    Occup Environ Med 2022.

    DOI PUBMED
  • article Plourde KV, Labrie Y, Ouellette G, Pouliot MC, Durocher F

    Genome-wide methylation analysis of DNMT3B gene isoforms revealed specific methylation profiles in breast cell lines

    Epigenomics 8 (9), 2016.

    DOI PUBMED
  • article Bouffard F, Plourde K, Belanger S, Ouellette G, Labrie Y, Durocher F

    Analysis of a FANCE Splice Isoform in Regard to DNA Repair

    J Mol Biol 427 (19), 2015.

    DOI PUBMED
  • article Bélanger S, Plourde KV, Beauparlant CJ, St-Laurent Pedneault C, Bouffard F, Ouellette G, Labrie Y, Durocher F

    Impaired Effects of a FANCC Splicing Isoform in FANC-BRCA DNA Repair Pathway

    J Genet Syndr Gene Ther 4 (5), 2013.

    DOI
  • article St-Laurent Pedneault C, Plourde K, Bélanger K, Bélanger S, Ouellette G, Bouffard F, Labrie Y, Durocher F

    Regulated Expression of a FANCL Splicing Variant as a Potential Modifier of DNA Repair Activity

    J Genet Syndr Gene Ther 4 (5), 2013.

    DOI
  • article Spurdle M, Marquart L, McGuffog L, Healey S, Sinilnikova OM, Wan F, Chen X, Beesley J, Singer CF, Dressler AC, Gschwantler-Kaulich D, Blum JL, Tung N, Weitzel JN, Lynch HT, Garber JE, Easton D, Peock S, Cook M, Oliver CT, Frost D, Conroy D, Evans DG, Lalloo F, Eeles RA, Izatt L, Davidson R, Chu C, Eccles D, Selkirk CG, Daly MB, Isaacs C, Stoppa-Lyonnet D, Buecher B, Belotti M, Mazoyer S, Barjhoux L, Verny-Pierre C, Lasset C, Dreyfus H, Pujol P, Collonge-Rame MA, Rookus MA and and Verhoef S, Kriege M, Hoogerbrugge N, Ausems MG, van Os TA, Wijnen JT, Devilee P, Meijers-Heijboer HE, Blok MJ, Heikkinen T, Nevanlinna HA, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Durocher F, Couch FJ, Lindor NM, Wang X, Domchek SM, Thomassen M, Nathanson KL, Caligo MA, Jernstrom HC, Liljegren A, Ehrencrona H, Karlsson P, Ganz PA, Olopade OI and and Tomlinson G, Neuhausen SL, Antoniou AC, Chenevix-Trench G, Rebbeck TR

    Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers

    Cancer Epidemiol Biomarkers Prev 20 (5), 2011.

    DOI PUBMED
  • article Guénard F, Durocher F

    BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase))

    Atlas Genet Cytogenet Oncol Haematol 14 (7), 2010.

    DOI
  • article Guénard F, Durocher F

    BRCA2 (breast cancer 2, early onset)

    Atlas Genet Cytogenet Oncol Haematol 14 (12), 2010.

  • article Guénard F, Durocher F

    DHX9 (DEAH (Asp-Glu-Ala-His) box polypeptide 9)

    Atlas Genet Cytogenet Oncol Haematol 14 (6), 2009.

  • chapitre Durocher F, Guénard F, Desjardins S, Ouellette G, Labrie Y

    Inherited susceptibility to breast cancer: accomplishments and challenges

    In: Sinnett D (ed.): (Molecular genetics of cancer), p. 19-93, p. 2005, ISBN: 8130800683, .